Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System
Journal of Developmental Biology · 27.06.2025 · 13 (3) · 22
DOI: 10.3390/jdb13030022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Developmental Biology, online erschienen am 27.06.2025. Verfasst von Nathan Zimmerman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Creighton University, Omaha, NE 68178, USA. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institute for AIDS and Infectious Disease (NIAID).
Abstract (Originalsprache)
Cholesterol homeostasis is necessary for normal vertebrate development. The disruption of cholesterol homeostasis can cause abnormal body and nervous system development and lead to dysfunctional behavior and increased mortality. Commonly prescribed psychopharmaceuticals can alter cholesterol synthesis and may disrupt early vertebrate development. A high-throughput vertebrate zebrafish model system was used to test the hypothesis that exposure to psychopharmaceutical medications alters cholesterol biosynthesis and disrupts gene transcription, early whole-body and brain development, and nervous system function, resulting in abnormal behavior. Exposure to cariprazine, aripiprazole, trazodone, and AY9944 increased 7-dehydrocholesterol levels compared to vehicle-treated zebrafish. Significant differences in disease-associated gene expression, brain structure, and functional behaviors were observed in psychopharmaceutical and AY9944-treated zebrafish compared to controls. These data reveal that the high-throughput zebrafish model system can discern psychopharmaceutical effects on cholesterol synthesis, gene transcription, and key features of early vertebrate development that influences behavior.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biology, Creighton University, Omaha, NE 68178, USA.
- Department of Biomedical Sciences, Creighton University, Omaha, NE 68178, USA.
- Department of Pediatrics, Department of Biochemistry & Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE 68178, USA.
- Departments of Psychiatry, Biochemistry & Molecular Biology, Pharmacology & Experimental Neuroscience and Munroe-Meyer Institute for Genetics and Rehabilitation, University of Nebraska Medical Center, Omaha, NE 68106, U…
ORCID-Profile: Carly Baker, Zeljka Korade, Károly Mirnics
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institute for AIDS and Infectious Disease (NIAID)
- NE-INBRE National Institute for General Medical Science (NIGMS)
- National Institutes of Health (NIH)
- Creighton University George F. Haddix Faculty Research Fund
Zitieren
APA
Zimmerman, N., Marta, A., Baker, C., Korade, Z., Mirnics, K., & Shibata, A. (2025). Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System. Journal of Developmental Biology, 13(3), 22. https://doi.org/10.3390/jdb13030022
Vancouver
Zimmerman N, Marta A, Baker C, Korade Z, Mirnics K, Shibata A. Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System. Journal of Developmental Biology. 2025;13(3):22. doi:10.3390/jdb13030022
BibTeX
@article{Zimmerman2025,
author = {Zimmerman, Nathan and Marta, Aaron and Baker, Carly and Korade, Zeljka and Mirnics, Károly and Shibata, Annemarie},
title = {Investigating Psychopharmaceutical Effects on Early Vertebrate Development Using a Zebrafish Model System},
journal = {Journal of Developmental Biology},
year = {2025},
volume = {13},
number = {3},
pages = {22},
doi = {10.3390/jdb13030022}
}
EUVIMED